Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.ygyno.2012.04.002
DC FieldValue
dc.titleSecond primary malignancies among women with uterine sarcoma
dc.contributor.authorKoivisto-Korander, R.
dc.contributor.authorScélo, G.
dc.contributor.authorFerro, G.
dc.contributor.authorMellemkjaer, L.
dc.contributor.authorHemminki, K.
dc.contributor.authorWeiderpass, E.
dc.contributor.authorTamaro, S.
dc.contributor.authorPompe-Kirn, V.
dc.contributor.authorTracey, E.
dc.contributor.authorBrewster, D.H.
dc.contributor.authorKliewer, E.V.
dc.contributor.authorTonita, J.M.
dc.contributor.authorKee-Seng, C.
dc.contributor.authorJonasson, J.G.
dc.contributor.authorMartos, C.
dc.contributor.authorBrennan, P.
dc.contributor.authorStraif, K.
dc.contributor.authorPukkala, E.
dc.date.accessioned2014-11-26T05:04:53Z
dc.date.available2014-11-26T05:04:53Z
dc.date.issued2012-07
dc.identifier.citationKoivisto-Korander, R., Scélo, G., Ferro, G., Mellemkjaer, L., Hemminki, K., Weiderpass, E., Tamaro, S., Pompe-Kirn, V., Tracey, E., Brewster, D.H., Kliewer, E.V., Tonita, J.M., Kee-Seng, C., Jonasson, J.G., Martos, C., Brennan, P., Straif, K., Pukkala, E. (2012-07). Second primary malignancies among women with uterine sarcoma. Gynecologic Oncology 126 (1) : 30-35. ScholarBank@NUS Repository. https://doi.org/10.1016/j.ygyno.2012.04.002
dc.identifier.issn00908258
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/109042
dc.description.abstractObjective: Uterine sarcomas (US) are rare malignancies with unclear aetiology. Studies on uterine sarcomas in the setting of second primary malignant tumours can provide clues to aetiology and identify side effects of different treatments. Methods: A cohort of 8606 cases of US was extracted from the data from 13 cancer registries and followed for second primary cancers within the period 1943-2000. Standardized incidence ratios (SIRs) were calculated, and Poisson regression analyses were performed. Results: There were 499 cancer cases observed after a first diagnosis of US (SIR 1.26, 95%CI 1.16-1.38). SIRs were elevated for cancers of the mouth and pharynx (2.16, 95%CI 1.15-3.69), colorectum (1.60, 95%CI 1.28-1.98), lung (1.73, 95%CI 1.27-2.29), breast (1.25, 95%CI 1.05-1.49), urinary bladder (1.74, 95%CI 1.02-2.79), kidney (2.00, 95%CI 1. 24-3.06), thyroid gland (2.74, 95%CI 1.42-4.79), and soft tissue sarcoma (5.23, 95%CI 2.51-9.62). The risk of breast cancer increased along with increasing age of US diagnosis (p trend 0.040). The risk of kidney cancer increased along with decreasing age of US diagnosis (p trend 0.004) and short time since the US diagnosis (p trend 0.018). Conclusions: Our study demonstrated increased risk of certain cancers following a diagnosis of US. The elevated risk for breast cancer may indicate shared hormonal aetiology, while the increased risk of colorectal and bladder cancers after US may be caused by radiation therapy of US. The clustering of smoking-related cancers after US is worth exploring in the future. © 2012 Elsevier Inc. All rights reserved.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/j.ygyno.2012.04.002
dc.sourceScopus
dc.subjectEndometrial stromal sarcoma
dc.subjectMulti-centre cohort study
dc.subjectSecond primary cancer
dc.subjectUterine leiomyosarcoma
dc.subjectUterine sarcoma
dc.typeArticle
dc.contributor.departmentSAW SWEE HOCK SCHOOL OF PUBLIC HEALTH
dc.description.doi10.1016/j.ygyno.2012.04.002
dc.description.sourcetitleGynecologic Oncology
dc.description.volume126
dc.description.issue1
dc.description.page30-35
dc.description.codenGYNOA
dc.identifier.isiut000305878400007
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

3
checked on Nov 13, 2019

WEB OF SCIENCETM
Citations

3
checked on Nov 13, 2019

Page view(s)

30
checked on Nov 9, 2019

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.